Advanced materials for cancer treatment and beyond

Area of Science:

• Biomaterials science and Nanotechnology in Oncology
• Advanced drug delivery systems for cancer therapy

Background:

• Conventional cancer treatments like chemotherapy and surgery have limitations, including lack of tumor specificity and the challenge of multidrug resistance (MDR).
• There is a growing need for innovative therapeutic materials that can specifically target cancer cells and overcome treatment resistance.

Purpose of the Study:

• To review recently developed therapeutic materials for cancer treatment that offer advantages over traditional methods.
• To highlight materials with anti-MDR properties, controllable treatment features, and high detection sensitivity.
• To discuss materials incorporating immune-enhancement, tumor microenvironment (TME) responsiveness, and integrated therapeutic/imaging capabilities.

Main Methods:

• Review of recent scientific literature on novel anti-cancer therapeutic materials.
• Analysis of material properties including biocompatibility, specificity, detection sensitivity, and functional modifications.
• Categorization of materials based on their therapeutic approach (e.g., immune-enhancing, TME-responsive, theranostic).

Main Results:

• Emerging therapeutic materials demonstrate high efficacy, specificity, and biocompatibility.
• These materials can be designed for controllable drug release and enhanced detection sensitivity.
• Approaches include immune-enhancing, TME-responsive, and theranostic (therapeutic and imaging) materials, along with advanced targeting modifications.

Conclusions:

• Novel therapeutic materials represent a significant advancement in cancer treatment, offering solutions to MDR and improving treatment control.
• These materials provide opportunities for precise, timely, and potentially less toxic cancer interventions.
• Further development and application of advanced modification strategies will enhance their targeting capabilities and clinical utility.